🇺🇸 bepotastine besilate, 1.5% in United States

bepotastine besilate, 1.5% (bepotastine besilate, 1.5%) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

bepotastine besilate, 1.5% in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is bepotastine besilate, 1.5% approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for bepotastine besilate, 1.5% in United States?

Southern California College of Optometry at Marshall B. Ketchum University is the originator. The local marketing authorisation holder may differ — check the official source linked above.